Article
Cystic fibrosis mutations lead to carboxyl-terminal fragments that highlight an early biogenesis step of the cystic fibrosis transmembrane conductance regulator.
The Journal of biological chemistry - 30 Jun 2000
Van Oene M, Lukacs G L, Rommens J M
Abstract excerpt
Inefficient delivery of the cystic fibrosis transmembrane conductance regulator (CFTR) to the surface of cells contributes to disease in the majority of cystic fibrosis patients. Analysis of cystic fibrosis-associated missense mutations in the first nucleotide binding domain (NBD1), including A455E, S549R, Y563N, and P574H, revealed reduced levels of mature CFTR with elevated levels of carboxyl-terminal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
